Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBruising at the injection site is one of the most common things people notice after starting Mounjaro. It happens because the needle passes through small blood vessels under the skin, causing a little pooling of blood in the tissue. Most bruises are small, fade within a few days, and are not a sign that anything has gone wrong. That said, knowing why it happens and how to reduce it makes a real difference. Mounjaro (tirzepatide) is a prescription-only medicine; your prescriber is the right person to assess any skin reaction that concerns you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen delivers tirzepatide into the subcutaneous fat just beneath the skin. That layer is threaded with tiny capillaries. When the needle tip clips one of them, blood seeps into the surrounding tissue and pools, producing the familiar purple-to-yellow bruise that develops over the next few hours. It is a mechanical process, not a sign that the medication is causing harm.
Bruise size varies considerably from person to person. People who take anticoagulants, low-dose aspirin, certain anti-inflammatory medicines, or high-dose fish-oil supplements are more prone to larger or darker marks because their blood takes longer to clot. Alcohol has a similar thinning effect. Age and skin type matter too, thinner skin, particularly on the abdomen, tends to bruise more readily than the thicker tissue of the outer thigh or upper arm. The NHS tirzepatide patient information confirms that injection-site reactions including bruising are among the most commonly reported effects, typically mild and short-lived.
If you are curious about the broader picture of how tirzepatide works and why a subcutaneous injection is the delivery route, our overview of tirzepatide covers the mechanism in plain terms.
Technique matters more than most people expect. Pinching a fold of skin before inserting the pen lifts the fat layer away from muscle and reduces the chance of the needle going too deep. Do not press the pen hard into the skin, let the KwikPen's auto-insert do the work. After the injection, apply gentle pressure with a clean cotton pad for ten to fifteen seconds. Do not rub: rubbing spreads blood into surrounding tissue and makes a bruise more visible.
Temperature can help too. A cold compress held against the site for a minute before injecting causes capillaries to constrict slightly, reducing blood flow and therefore the risk of a visible mark. Some people find applying a cold pack immediately afterwards limits the size of a bruise that has already started to form.
Rotation is the most important long-term habit. Using the same patch of skin repeatedly leaves scar tissue that is harder to inject cleanly and more likely to bruise. Switch between the abdomen (at least two inches from the navel), the front of the thigh and the upper arm, and within each site vary the exact spot each week. There is more detail on this in our guide to why Mounjaro causes bruising and in the section on bruising easily on Mounjaro. People who want to review the specifics of the Mounjaro treatment itself will find the full licensed details there.
Most injection-site bruises shrink and fade within three to seven days without any intervention. A bruise that covers a small area, is not warm to the touch, and is not getting bigger after the first day is almost certainly routine. Watch for a few things that shift it into a different category.
Seek advice from your prescriber or GP promptly if: the bruised area is hot, swollen, and increasingly painful (these can signal infection or an abscess, which is uncommon but treatable); the bruise is growing after 48 hours rather than stabilising; you are noticing bruises appearing away from injection sites for no obvious reason; or you develop a firm lump under the skin that does not resolve. The last point can indicate lipohypertrophy (thickened fatty tissue from repeated injections in one spot) which affects absorption as well as comfort.
The MHRA's Yellow Card scheme exists precisely for situations where a side effect feels unexpected or significant. Reporting there helps regulators track real-world experience with newer medicines including Mounjaro, which still carries the Black Triangle (▼) status indicating it is under additional monitoring. For bruising patterns that seem unusual, your prescriber is also the right first call. You can read about Mounjaro bruising in more detail, or check whether Mounjaro can cause bruising on the legs if that is the specific area you have noticed.
If you are on Mounjaro through a private clinic or pharmacy, most teams offer ongoing support. At nume, aftercare is available seven days a week, reach out via our contact page if something does not feel right. And if you are not yet on treatment and are considering your options, starting a free consultation is the first step toward a same-day clinical review by one of our GPhC-registered prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.